AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Trastuzumab Emtansine in Kenya
2 products registered with PPB — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Kadcyla 100 mg Powder For Concentrate For Solution For Infus | H2022/CTD9713/21694 | F. Hoffman-La Roche Ltd | active | 11 Apr 2028 |
| Kadcyla 160 mg Powder For Concentrate For Solution For Infus | H2022/CTD9715/21695 | F. Hoffmann-La Roche Ltd. | active | 11 Apr 2028 |
Trastuzumab Emtansine — PPB Registration Details
PPB (Kenya) has 2 registered products containing Trastuzumab Emtansine, of which 2 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Trastuzumab Emtansine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.